Kjær Andreas, Torigian Drew A
Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Denmark.
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
PET Clin. 2016 Oct;11(4):489-93. doi: 10.1016/j.cpet.2016.05.010. Epub 2016 Jul 27.
In 2011, the first fully integrated commercially available clinical PET/MR imaging systems became available, and the imaging community thought that these scanners would replace PET/CT systems. However, today a disappointing number of less than 100 scanners have been installed worldwide. The question, therefore, arises regarding what the future clinical applications of PET/MR imaging will be. In this article, the authors discuss ways in which PET/MR imaging may be used in future applications that justify the added cost, predominantly focusing on oncologic applications. The authors suggest that such areas include combined molecular and functional imaging, multimodality radiomics, and hyperPET.
2011年，首批完全集成的商用临床PET/MR成像系统问世，当时影像学界认为这些扫描仪将取代PET/CT系统。然而，如今全球安装的扫描仪数量不足100台，令人失望。因此，关于PET/MR成像未来的临床应用将会是什么的问题便出现了。在本文中，作者探讨了PET/MR成像在未来应用中可能的使用方式，这些应用能够证明其额外成本的合理性，主要聚焦于肿瘤学应用。作者认为这些领域包括分子与功能联合成像、多模态放射组学以及超PET。
